GB1564135A - Readily-assimilatable highly-soluble calcium and/or magnesium organic salts - Google Patents

Readily-assimilatable highly-soluble calcium and/or magnesium organic salts Download PDF

Info

Publication number
GB1564135A
GB1564135A GB31669/76A GB3166976A GB1564135A GB 1564135 A GB1564135 A GB 1564135A GB 31669/76 A GB31669/76 A GB 31669/76A GB 3166976 A GB3166976 A GB 3166976A GB 1564135 A GB1564135 A GB 1564135A
Authority
GB
United Kingdom
Prior art keywords
magnesium
calcium
water
salts
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB31669/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BUCURESTI MEDICAMENTE
Zentiva SA
Original Assignee
BUCURESTI MEDICAMENTE
Intreprinderea de Medicamente Bucuresti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BUCURESTI MEDICAMENTE, Intreprinderea de Medicamente Bucuresti filed Critical BUCURESTI MEDICAMENTE
Publication of GB1564135A publication Critical patent/GB1564135A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB31669/76A 1975-08-05 1976-07-29 Readily-assimilatable highly-soluble calcium and/or magnesium organic salts Expired GB1564135A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO7583091A RO68298A2 (ro) 1975-08-05 1975-08-05 Compozitie pe baza de saruri organice de calciu si magneziu usor asimilabile si cu o solubilitate crescuta,si procedeu de preparare a acesteia

Publications (1)

Publication Number Publication Date
GB1564135A true GB1564135A (en) 1980-04-02

Family

ID=20095205

Family Applications (1)

Application Number Title Priority Date Filing Date
GB31669/76A Expired GB1564135A (en) 1975-08-05 1976-07-29 Readily-assimilatable highly-soluble calcium and/or magnesium organic salts

Country Status (7)

Country Link
JP (1) JPS54122216A (enrdf_load_stackoverflow)
CH (1) CH625503A5 (enrdf_load_stackoverflow)
DE (1) DE2635293A1 (enrdf_load_stackoverflow)
FR (1) FR2320089A1 (enrdf_load_stackoverflow)
GB (1) GB1564135A (enrdf_load_stackoverflow)
IN (1) IN144366B (enrdf_load_stackoverflow)
RO (1) RO68298A2 (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101209962B (zh) * 2006-12-28 2011-08-24 浙江山下湖珍珠集团股份有限公司 一种葡萄糖酸钙镁的制备方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU84891A1 (fr) * 1983-06-30 1985-03-29 Continental Pharma Derives de l'acide 2-aminoacetique,leur preparation et utilisation ainsi que compositions pharmaceutiques contenant ces derives
US5089276A (en) * 1989-04-19 1992-02-18 Takeda Chemical Industries, Ltd. Calcium pantothenate composite
GB8926486D0 (en) * 1989-11-23 1990-01-10 Ciba Geigy Pesticide composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2454164A1 (de) * 1974-11-15 1976-05-26 Tad Pharm Werk Injektions- bzw. infusionsloesung zur bekaempfung von tetanien bei wiederkaeuern und verfahren zur herstellung derselben

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101209962B (zh) * 2006-12-28 2011-08-24 浙江山下湖珍珠集团股份有限公司 一种葡萄糖酸钙镁的制备方法

Also Published As

Publication number Publication date
IN144366B (enrdf_load_stackoverflow) 1978-04-29
JPS54122216A (en) 1979-09-21
JPS5761728B2 (enrdf_load_stackoverflow) 1982-12-25
DE2635293A1 (de) 1977-05-12
CH625503A5 (en) 1981-09-30
RO68298A2 (ro) 1980-04-15
FR2320089B1 (enrdf_load_stackoverflow) 1978-11-17
FR2320089A1 (fr) 1977-03-04

Similar Documents

Publication Publication Date Title
DE2910221C2 (enrdf_load_stackoverflow)
US4320146A (en) Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids
DE3779500T2 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
DE69901396T2 (de) Zusammensetzung enthaltend beta-hydroxy-beta-methylbutyratsäuere und mindestens ein aminosäure
DE69030616T2 (de) Pharmazeutische Zusammensetzungen zur Hemmung der Maillardreaktion
JPS5946947B2 (ja) （＋）カテキン塩
EP0203649A2 (en) Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis
US3352754A (en) Therapeutic compositions comprising isoflavone compounds
KR920004391A (ko) 치환된 카복실산의 코데인 염, 이의 제조방법, 이의 용도 및 약제학적 조성물
DE3000743C2 (de) Arzneipräparat auf der Basis eines Salzes der Acetylsalicylsäure und einer basischen Aminosäure
GB1564135A (en) Readily-assimilatable highly-soluble calcium and/or magnesium organic salts
DE2166355C2 (de) Verwendung von d,1-Sobrerol bei der Balsamtherapie der Atemwege
JPS60120995A (ja) 新規アミノ酸誘導体の製法
JPH07223940A (ja) 活性酸素消去剤及びこれを含有する組成物
EP0030023A3 (en) A heterocyclic compound and its synthesis, pharmaceutical formulations thereof and the use of the compounds and the formulations in medicine
DE1806926A1 (de) Lithiumsalz der Hydrochinonsulfonsaeure
US4001231A (en) Process for making a methenamine salt of an optically active acid
Modell Drugs in Current Use 1958
DE69323998T2 (de) Pharmazeutisch aktive flavilium verbindungen
DE2408372C3 (de) Therapeutisch verträgliche Salze der p-Chlorhippursäure und diese oder p-Chlorhippursäure enthaltende pharmazeutische Zubereitungen
Proskouriakoff Some Salts of Levulinic Acid1
JP3178763B2 (ja) シムノールサルフェート製造法
US2192386A (en) Insulin preparation and process
US2165470A (en) Amine salt preparations for internal medication
US2414650A (en) Bismuth compounds

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee